PR Newswire
UNION CITY, Calif., Aug. 3, 2017
UNION CITY, Calif., Aug. 3, 2017 /PRNewswire/ -- Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Clint Severson, Chairman and Chief Executive Officer, will present at the Canaccord Genuity 37th Annual Growth Conference on Wednesday, August 9, 2017 at 4:30 p.m. ET. The conference will be held at InterContinental Hotel in Boston, MA.
About Abaxis
Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Our mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. We provide leading edge technology, tools and services that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. For more information, visit http://www.abaxis.com.
Contact: | Clint Severson | Lytham Partners, LLC |
| Chief Executive Officer | Joe Dorame, Joe Diaz & Robert Blum |
| ABAXIS, Inc. | 602-889-9700 |
| 510-675-6500 | |
View original content:http://www.prnewswire.com/news-releases/abaxis-inc-to-present-at-the-canaccord-genuity-37th-annual-growth-conference-300498910.html
SOURCE Abaxis, Inc.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.